University Of Melbourne
Clinical trials sponsored by University Of Melbourne, explained in plain language.
-
Could a cancer drug help control HIV?
Disease control Recruiting nowThis study is testing if a single, low dose of the immunotherapy drug nivolumab can help reduce the hidden, inactive 'reservoir' of HIV in the body. It involves 42 adults living with HIV who are on stable antiretroviral therapy. The goal is to see if this approach can help the im…
Phase: PHASE1, PHASE2 • Sponsor: University of Melbourne • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Race against time: new surgery aims to save brain function after major stroke
Disease control Recruiting nowThis study is testing whether performing a minimally invasive surgery to remove a blood clot from the brain within 8 hours of a severe stroke leads to better recovery than standard medical care. It will involve 240 adults who have had a significant brain bleed. The main goal is t…
Phase: NA • Sponsor: University of Melbourne • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Global race to beat deadly blood infection
Disease control Recruiting nowThis large international trial aims to find the best antibiotic treatments to reduce deaths from Staphylococcus aureus bacteremia, a serious and often fatal blood infection. It will enroll 8,000 hospitalized patients and uses a smart, adaptive design to quickly identify which of …
Phase: PHASE4 • Sponsor: University of Melbourne • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Scientists hunt for early warning signs of deadly thunderstorm asthma
Knowledge-focused Recruiting nowThis study aims to find biological markers that can predict who is at high risk for severe asthma attacks during spring pollen seasons and thunderstorms. Researchers will track 530 adults with hay fever in Australia over two years, monitoring their symptoms and testing their bloo…
Phase: NA • Sponsor: University of Melbourne • Aim: Knowledge-focused
Last updated Mar 12, 2026 13:51 UTC